An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice.

An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice.
复制标题

DOI:
10.1126/sciimmunol.aba5264
复制
发表时间:
2020-08-14
期刊:
影响因子:
24.8
通讯作者:
Gavin MA
Gavin MA
中科院分区:
医学1区
文献类型:
--
作者:
Khoryati L;Pham MN;Sherve M;Kumari S;Cook K;Pearson J;Bogdani M;Campbell DJ;Gavin MA

文献摘要

参考文献

被引文献

相似文献

白细胞介素-2(IL-2)控制调节性T(Treg)细胞的稳态和功能,并且IL-2途径中的缺陷促成多种自身免疫性疾病。尽管重组IL-2疗法在某些炎性病症中是有效的,但IL-2也激活炎性效应子应答的能力突出了对具有改善的Treg细胞特异性的基于IL-2的治疗剂的需要。从一组合理设计的鼠IL-2变体中,我们鉴定了由于对IL-2受体组分CD 25的依赖性增加而具有降低的效力和增强的Treg细胞选择性的IL-2突变蛋白。作为Fc融合的同二聚体,最佳Fc.IL-2突变蛋白诱导选择性Treg细胞富集,并在宽剂量范围内降低效应细胞的激动作用。此外,尽管是较弱的激动剂,但总体Treg细胞生长更大且更持续,这是由于与Fc融合的野生型IL-2相比,Fc.IL-2突变蛋白的受体介导的清除减少。在非肥胖糖尿病(NOD)小鼠胰腺中存在活化的致病性T细胞的情况下也观察到优先Treg细胞富集,尽管在IL-2 R近端应答中Treg细胞选择性丧失。这些特性有助于在不频繁给药的情况下有效和延长NOD糖尿病的消退。CD 25依赖性IL-2突变蛋白扩增调节性T细胞并控制非肥胖糖尿病(NOD)小鼠的自发性糖尿病。
Interleukin-2 (IL-2) controls the homeostasis and function of regulatory T (Treg) cells and defects in the IL-2 pathway contribute to multiple autoimmune diseases. Although recombinant IL-2 therapy has been efficacious in certain inflammatory conditions, the capacity for IL-2 to also activate inflammatory effector responses highlights the need for IL-2-based therapeutics with improved Treg cell-specificity. From a panel of rationally designed murine IL-2 variants, we identified IL-2 muteins with reduced potency and enhanced Treg cell-selectivity due to increased dependence on the IL-2-receptor component CD25. As an Fc-fused homodimer, the optimal Fc.IL-2 mutein induced selective Treg cell enrichment and reduced agonism of effector cells across a wide dose range. Furthermore, despite being a weaker agonist, overall Treg cell growth was greater and more sustained due to reduced receptor-mediated clearance of the Fc.IL-2 mutein compared to Fc-fused wild-type IL-2. Preferential Treg cell enrichment was also observed in the presence of activated pathogenic T cells in the pancreas of non-obese diabetic (NOD) mice, despite a loss of Treg cell-selectivity in an IL-2R-proximal response. These properties facilitated potent and extended resolution of NOD diabetes with infrequent dosing schedules. A CD25-dependent IL-2 mutein expanded regulatory T cells and controlled spontaneous diabetes in non-obese diabetic (NOD) mice.
控制FOXP3基因座中的顺式元素对调节T细胞身份的遗传控制。
DOI: 10.1016/j.cell.2014.07.031
发表时间: 2014-08-14
期刊: Cell
影响因子: 64.5
作者:
Feng Y;Arvey A;Chinen T;van der Veeken J;Gasteiger G;Rudensky AY
通讯作者: Rudensky AY
DOI: 10.1074/jbc.m116.748525
发表时间: 2017-02-03
影响因子: 4.8
作者:
Jacobsen, Frederick W.;Stevenson, Riki;Gunasekaran, Kannan
通讯作者: Gunasekaran, Kannan
DOI: 10.1056/nejmoa1902226
发表时间: 2019-08-15
影响因子: 158.5
作者:
Herold, Kevan C.;Bundy, Brian N.;Greenbaum, Carla J.
通讯作者: Greenbaum, Carla J.
DOI: 10.3389/fimmu.2019.02665
发表时间: 2019-11-25
影响因子: 7.3
作者:
Godoy,Gloria J.;Olivera,Carolina;Rivero,Virginia E.
通讯作者: Rivero,Virginia E.
DOI: 10.1016/s2665-9913(19)30018-9
发表时间: 2019-09-01
影响因子: 25.4
作者:
Humrich, Jens Y.;Von Spee-Mayer, Caroline;Riemekasten, Gabriela
通讯作者: Riemekasten, Gabriela